" class="no-js "lang="en-US"> Camber Pharma Launches Generic Kaletra - Medtech Alert
Thursday, February 09, 2023

Camber Pharma Launches Generic Kaletra

Camber Pharmaceuticals is pleased to announce that it has launched Lopinavir and RitonavirTablets, which is the generic version of Kaletra®

Lopinavir and Ritonavir Tablets are used with other HIV medications to help control HIV infection.Lopinavir and Ritonavir Tablets are available from Camber in 100 mg/25 mg- 60 count and 200 mg/50 mg- 120 count bottles.

Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.

Companies In This Post

  1. ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Read more
  2. Superior HealthPlan and eFamilyCare Expand Partnership to Support Medicaid Members and Caregivers in Texas Read more
  3. Garuda Therapeutics Secures $62 Million Series B Financing to Advance Off-the-Shelf Blood Stem Cell Technology Platform Read more
  4. FSD Pharma Receives Regulatory Clearance for Its Proposed Phase-1 Clinical Trial of Lucid-21-302 (Lucid-MS), First-in-Class Multiple Sclerosis Drug Candidate Read more
  5. $25 Million Gift to Penn Medicine and Children’s Hospital of Philadelphia Establishes Center for Epilepsy and Neurodevelopmental Disorders Read more